• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病:遗传咨询与群体筛查

Gaucher's disease: genetic counselling and population screening.

作者信息

Levy-Lahad E, Zimran A

机构信息

Medical Genetic Services, Shaare-Zedek Medical Center, Jerusalem, Israel.

出版信息

Baillieres Clin Haematol. 1997 Dec;10(4):779-92. doi: 10.1016/s0950-3536(97)80040-6.

DOI:10.1016/s0950-3536(97)80040-6
PMID:9497864
Abstract

Genetic counselling for Gaucher's disease requires a comprehensive approach, including accurate diagnosis at both the enzymatic and molecular levels, and assessment of disease severity. These goals are particularly challenging given the great allelic and phenotypic heterogeneity encountered in this disorder. Counselling should address the specific concerns of the counsellee, which may be related to evaluation of an affected person, or to reproductive options in couples at risk. Advances in both diagnosis and treatment have led to increased ascertainment of cases and carriers through population based screening, rather than through affected probands, raising new ethical and medical dilemmas. This chapter outlines practical issues in counselling for the various forms of Gaucher's disease, based on current data and experience.

摘要

戈谢病的遗传咨询需要一种全面的方法,包括在酶学和分子水平上进行准确诊断,以及评估疾病严重程度。鉴于这种疾病存在巨大的等位基因和表型异质性,实现这些目标极具挑战性。咨询应解决被咨询者的具体担忧,这些担忧可能与对患者的评估有关,或与有风险夫妇的生殖选择有关。诊断和治疗方面的进展导致通过基于人群的筛查而非通过受影响的先证者来增加病例和携带者的确诊率,这引发了新的伦理和医学困境。本章根据当前数据和经验概述了各种类型戈谢病咨询中的实际问题。

相似文献

1
Gaucher's disease: genetic counselling and population screening.戈谢病:遗传咨询与群体筛查
Baillieres Clin Haematol. 1997 Dec;10(4):779-92. doi: 10.1016/s0950-3536(97)80040-6.
2
Gaucher's disease: molecular, genetic and enzymological aspects.戈谢病:分子、遗传及酶学方面
Baillieres Clin Haematol. 1997 Dec;10(4):635-56. doi: 10.1016/s0950-3536(97)80032-7.
3
Gaucher's disease in pregnancy.妊娠期戈谢病
Obstet Gynecol Surv. 1996 Sep;51(9):549-58. doi: 10.1097/00006254-199609000-00022.
4
Phenotypic continuum of type 2 Gaucher's disease: an intermediate phenotype between perinatal-lethal and classic type 2 Gaucher's disease.2型戈谢病的表型连续体:围产期致死型和经典2型戈谢病之间的中间表型。
J Perinatol. 2009 Feb;29(2):170-2. doi: 10.1038/jp.2008.179.
5
Gaucher's disease: diagnosis, treatment, and management.戈谢病:诊断、治疗与管理
J Am Acad Nurse Pract. 1997 Jun;9(6):283-7. doi: 10.1111/j.1745-7599.1997.tb00722.x.
6
Genetic diagnosis of Gaucher's disease.戈谢病的基因诊断。
Lancet. 1992 Apr 11;339(8798):889-92. doi: 10.1016/0140-6736(92)90928-v.
7
Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.戈谢病的携带者筛查:低外显率可治疗疾病的经验教训
JAMA. 2007 Sep 19;298(11):1281-90. doi: 10.1001/jama.298.11.1281.
8
Gaucher's disease: a review for the internist and hepatologist.戈谢病:内科医生和肝病学家的综述
Hepatogastroenterology. 2000 Jul-Aug;47(34):984-97.
9
Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype.以心脏瓣膜进行性钙化和独特基因型为特征的戈谢病变异型。
Lancet. 1995 Oct 14;346(8981):1000-3. doi: 10.1016/s0140-6736(95)91688-1.
10
[Case report of Gaucher's disease].[戈谢病病例报告]
Vutr Boles. 1987;26(4):77-83.

引用本文的文献

1
A 30-Year-Old Carrier of Gaucher Disease with Multiple Myeloma.一名患有戈谢病且患多发性骨髓瘤的30岁携带者。
Case Rep Oncol Med. 2019 Feb 13;2019:6469196. doi: 10.1155/2019/6469196. eCollection 2019.
2
Receiving enzyme replacement therapy for a lysosomal storage disorder: a preliminary exploration of the experiences of young patients and their families.接受溶酶体贮积症的酶替代疗法:对年轻患者及其家庭经历的初步探索。
J Genet Couns. 2013 Aug;22(4):517-32. doi: 10.1007/s10897-013-9579-1. Epub 2013 Mar 28.
3
Disease severity in sibling pairs with type 1 Gaucher disease.
1 型戈谢病同胞对疾病严重程度。
J Inherit Metab Dis. 2010 Feb;33(1):79-83. doi: 10.1007/s10545-009-9024-7. Epub 2010 Jan 5.
4
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement.亚氨基糖N-丁基脱氧野尻霉素(米格列醇)在I型(非神经病变型)戈谢病治疗中的作用:一份立场声明。
J Inherit Metab Dis. 2003;26(6):513-26. doi: 10.1023/a:1025902113005.
5
Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.导致轻度1型和重度2型戈谢病的非假基因衍生的复杂酸性β-葡萄糖苷酶突变
J Clin Invest. 1999 Mar;103(6):817-23. doi: 10.1172/JCI5168.